SELLAS Life Sciences (SLS) Revenue (2012 - 2022)

SELLAS Life Sciences (SLS) has 7 years of Revenue data on file, last reported at $1.0 million in Q1 2022.

• Quarterly Revenue fell 82.46% year-over-year to $1.0 million in Q1 2022, while the trailing twelve-month figure through Dec 2022 was $1.0 million (down 86.84% YoY) and the FY2022 annual result came in at $1.0 million, down 86.84% from the prior year.
• Revenue declined to $1.0 million in Q1 2022 per SLS's latest filing, from $1.9 million in the prior quarter.
• Across five years, Revenue topped out at $5.7 million in Q1 2021 and bottomed at $1.0 million in Q1 2022.
• The 3-year median for Revenue is $1.9 million (2020), against an average of $2.6 million.
• Peak annual rise in Revenue reached 82.46% in 2022, while the deepest fall reached 82.46% in 2022.
• Tracing SLS's Revenue over 3 years: stood at $1.9 million in 2020, then changed by 0.0% to $1.9 million in 2021, then tumbled by 47.37% to $1.0 million in 2022.
• Per Business Quant, the three latest SLS Revenue figures stand at $1.0 million (Q1 2022), $1.9 million (Q2 2021), and $5.7 million (Q1 2021).

Peer Comparison